Form 4 · Filed Jun 1, 2026, 10:31 PM UTC
PTGX/Protagonist Therapeutics, Inc
Waddill William D. — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 29, 2026 | M | other | 9,000 | $12 | $106,200 | 16,825 |
| May 29, 2026 | S | sell | 9,000 | $100 | $896,760 | 7,825 |
| May 29, 2026 | M | other | 9,000 | — | — | 3,000 |
Source: SEC EDGAR raw filing ↗ · Accession 0001104659-26-069047